“We are optimistic that an end to the HIV pandemic is feasible. However, to reach this goal, we must apply the tools and advances already at hand as we continue to follow the science in laboratories and clinics around the world. Today we honor the achievements of dedicated researchers, health care professionals, clinical trial participants and members of the global community, and we reaffirm our commitment to work together to fill the remaining gaps. [NIH news]
We were honored to have COL. Nelson Michael join us this year as our 2018 visiting professor.
“We eagerly await the results of the phase 2b Imbokodo’, which will determine whether or not this vaccine will protect humans against acquiring HIV.”
“An HIV vaccine that has the potential to protect people around the world from the virus has shown promising results.”
“These results represent an important milestone,” said Dan Barouch, professor of medicine at Harvard Medical School and lead author of the study.
“Although these data are promising, we need to remain cautious,” study leader Dan Barouch, a Harvard Medical School professor, told AFP. “This is only the fifth HIV vaccine concept that […]
“Dr. Dan Barouch, Professor of Medicine at Harvard Medical School and author of the study, told Newsweek he is “cautiously optimistic” about the results, but stressed there are many obstacles […]
“I would say that we are pleased with these data so far, but we have to interpret the data cautiously,” said study co-author Dr. Dan H. Barouch, a principal investigator […]
Dr. Dan Barouch with Mayor Marty Walsh at the Annual 2018 AIDS Walk and Run.
But in the latest report presented this month at the Conference on Retroviruses and Opportunistic Infections in Boston, researchers revealed the strongest evidence yet that these latent viruses can be […]
